Will Overall Growth Aid Thermo Fisher's (TMO) Q4 Earnings?
Zacks Investment Research | Jan 23, 2019 10:17PM ET
Thermo Fisher Scientific Inc. (NYSE:TMO) is slated to report fourth-quarter 2018 results, before the market opens on Jan 30. In the last reported quarter, the company delivered a positive earnings surprise of 2.75%. Moreover, its key metrics surpassed estimates in all the trailing four reported quarters, the average being 3.88%.
Let's see how things are shaping up for this announcement.
Key Catalysts
Thermo Fisher has been going strong with its analytical instrument business, boasting higher global demand. The company is witnessing balanced growth across all its businesses within this segment, particularly in chemical analysis, chromatography mass spectrometry and electron microscopy. Its acquisition of FEI has been largely contributing to its analytical instruments portfolio over the past year. Ever since, the company has introduced several products, which leverage its leading instrument platforms and digital capabilities.
Further, we are optimistic about a favorable NIH (National Institutes of Health) funding scenario. Per Thermo Fisher, NIH funds are flowing well and we are specifically upbeat about NIH's announcement in May to allocate $130 million to researchwork based on cryo-electron microscopy, which bodes well for spurring future demand. This is also a vital highlight of the company’s analytical instrument performance.
Thermo Fisher Scientific Inc. Price and EPS Surprise
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.